Results 221 to 230 of about 79,717,431 (252)

Prioritising search for virtual screening via preliminary interpretable low-feature likelihood-based rankings of drug-target activity measures. [PDF]

BMC Bioinformatics
Curcio R, Mancini T, Tronci E.
europepmc   +1 more source

Inebilizumab in AQP4‐Seropositive NMOSD: One‐Year Follow‐Up From a Multicenter, Real‐World Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Real‐world evidence on inebilizumab among neuromyelitis optica spectrum disorder (NMOSD) patients is lacking. This study assessed inebilizumab among Chinese patients with aquaporin 4 autoantibody (AQP4‐IgG)‐seropositive NMOSD in a real‐world setting.
Mengcui Gui, Jiayang Zhan, Wei Li, Tao Jin, Dan He, Daishi Tian, Zhijun Li, Jing Lin, Yue Li, Hongyu Zhou, Bitao Bu   +10 more
wiley   +1 more source

Evaluation and Comparison of Latent Health Risk Prediction Models for Clinical Triage: Protocol for a Mixed Methods Study. [PDF]

JMIR Res Protoc
Roberts M, Pelkonen O, Shamsutdinova D, Sanderson SC, Renc P, Logan Ellis H.   +5 more
europepmc   +1 more source

The Comprehensive Live Cell‐Based Cytotoxicity Assay for Monitoring Disease Activity and Guiding Rescue Therapy in Acute Attacks of NMOSD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neuromyelitis optica spectrum disorder (NMOSD) is a devastating neurological disease that lacks serological biomarkers that can accurately reflect disease activity. We established a live cell‐based assay (LCBA) using serum with endogenous complement to quantify the overall cytotoxicity, offering a novel functional tool for monitoring
Xiaona Xu, Jie Ding, Yupeng Du, Guibao Luo, Jinming Li, Rui Liu, Xiaoyi Xu, Xiao Li, Minshu Li, Wei Jiang, Chunsheng Yang   +10 more
wiley   +1 more source

Science-wide mapping of institutions based on affiliated authors' impact and research integrity proxies. [PDF]

R Soc Open Sci
Ioannidis J, Baas J, Boverhof R, Voyant C.   +3 more
europepmc   +1 more source

Exploratory Ising model network analysis of cluster headache: mapping conditional associations across symptoms, triggers, and pain localization. [PDF]

J Headache Pain
Togha M, Gargari OK, Khorvash F, Hoseinnezhad M, Jafari E, Derakhshesh A, Rahimi S, Shaygannejad V, Salami Z, Badiee-Gavarti M, Foroushani RS, Shaafi S, Haghdoost F.   +12 more
europepmc   +1 more source

Physicians and artificial intelligence diverge in evaluating large language models on real clinical cases. [PDF]

NPJ Digit Med
Shi P, Li J, Yang Z, Cao Y, Ju L, Bao H, Xu H, Fan Y, Ren T, Xiao Y, Zhu J, Chen J, Dong Y, Hu X, Tong Y, Wang Z, Xiang Y, Zhao J, Zhou J, Temelkuran B, Zhou Y, Jin L, Li C, Wang M, Xiong H, Keane PA, Ge J, Wang N.   +27 more
europepmc   +1 more source

Prioritising medication management criteria to identify emergency department patients with potential medication-related harm: Nominal Group Technique workshops with clinicians. [PDF]

Int J Clin Pharm
Franich A, Hill K, Grant G, Hattingh HL.
europepmc   +1 more source

What makes partnerships work? Measuring agreement in participant beliefs regarding 'core' reasons for success. [PDF]

PLoS One
Mathews MC, Drake AJ.
europepmc   +1 more source